866-997-4948(US-Canada Toll Free)

Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 126 Pages

This report studies the Nuclear Medicine Radiopharmaceuticals market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Nuclear Medicine Radiopharmaceuticals market by product type and applications/end industries.

The global Nuclear Medicine Radiopharmaceuticals market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nuclear Medicine Radiopharmaceuticals.

Europe also play important roles in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX.

The major players in global Nuclear Medicine Radiopharmaceuticals market include
Mallinckrodt
Isorad
Cardinal Health
Jubilant
Medi-Radiopharma
Comecer
Jaco
Ciaeriar
Advanced Molecular-imaging Solution


Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share (%) and Growth Rate (%) of Nuclear Medicine Radiopharmaceuticals in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

On the basis of product, the Nuclear Medicine Radiopharmaceuticals market is primarily split into
Diagnostic
Brachytherapy
Other Therapeutic

On the basis on the end users/applications, this report covers
Oncology
Thyroid
Cardiology
Others
Table of Contents

1 Nuclear Medicine Radiopharmaceuticals Market Overview
1.1 Nuclear Medicine Radiopharmaceuticals Product Overview
1.2 Nuclear Medicine Radiopharmaceuticals Segment by Types (Product Category)
1.2.1 Global Nuclear Medicine Radiopharmaceuticals Sales and Growth (%) Comparison by Types (2012-2022)
1.2.2 Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) by Types in 2016
1.2.3 Diagnostic
1.2.4 Brachytherapy
1.2.5 Other Therapeutic
1.3 Global Nuclear Medicine Radiopharmaceuticals Segment by Applications
1.3.1 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) Comparison by Applications (2012-2022)
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Global Nuclear Medicine Radiopharmaceuticals Market by Regions (2012-2022)
1.4.1 Global Nuclear Medicine Radiopharmaceuticals Market Size and Growth (%) Comparison by Regions (2012-2022)
1.4.2 North America Nuclear Medicine Radiopharmaceuticals Status and Prospect (2012-2022)
1.4.3 Asia-Pacific Nuclear Medicine Radiopharmaceuticals Status and Prospect (2012-2022)
1.4.4 Europe Nuclear Medicine Radiopharmaceuticals Status and Prospect (2012-2022)
1.4.5 South America Nuclear Medicine Radiopharmaceuticals Status and Prospect (2012-2022)
1.4.6 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Status and Prospect (2012-2022)
1.5 Global Nuclear Medicine Radiopharmaceuticals Market Size (2012-2022)
1.5.1 Global Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) Status and Outlook (2012-2022)
1.5.2 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) Status and Outlook (2012-2022)
2 Global Nuclear Medicine Radiopharmaceuticals Market Competition by Manufacturers/Brand
2.1 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Share by Manufacturers (2012-2017)
2.2 Global Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) and Share by Manufacturers (2012-2017)
2.3 Global Nuclear Medicine Radiopharmaceuticals Average Price (USD/Unit) by Manufacturers (2012-2017)
2.4 Manufacturers Nuclear Medicine Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types
2.5 Nuclear Medicine Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Nuclear Medicine Radiopharmaceuticals Market Concentration Rate
2.5.2 Nuclear Medicine Radiopharmaceuticals Market Share (%) of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD) by Regions (2012-2017)
3.2 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Market Share (%) by Regions (2012-2017)
3.3 Global Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) and Market Share (%) by Regions (2012-2017)
3.3 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5 North America Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.6 Europe Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.7 Asia-Pacific Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.8 South America Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
3.9 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
4 Global Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price Trend by Types
4.1 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Market Share (%) by Types (2012-2017)
4.2 Global Nuclear Medicine Radiopharmaceuticals Revenue and Market Share (%) by Types (2012-2017)
4.3 Global Nuclear Medicine Radiopharmaceuticals Price (USD/Unit) by Type (2012-2017)
4.4 Global Nuclear Medicine Radiopharmaceuticals Sales Growth by Type (2012-2017)
5 Global Nuclear Medicine Radiopharmaceuticals Market Analysis by Applications
5.1 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Market Share (%) by Applications (2012-2017)
5.2 Global Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) by Applications (2012-2017)
6 Global Nuclear Medicine Radiopharmaceuticals Manufacturers Profiles/Analysis
6.1 Mallinckrodt
6.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.1.2 Nuclear Medicine Radiopharmaceuticals Product Category, End Uses and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Mallinckrodt Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Isorad
6.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.2.2 Nuclear Medicine Radiopharmaceuticals Product Category, End Uses and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Isorad Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Cardinal Health
6.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.3.2 Nuclear Medicine Radiopharmaceuticals Product Category, End Uses and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Cardinal Health Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Jubilant
6.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.4.2 Nuclear Medicine Radiopharmaceuticals Product Category, End Uses and Specification
6.4.2.1 Product A
6.4.2.2 Product A
6.4.3 Jubilant Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Medi-Radiopharma
6.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.5.2 Nuclear Medicine Radiopharmaceuticals Product Category, End Uses and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Medi-Radiopharma Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Comecer
6.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.6.2 Nuclear Medicine Radiopharmaceuticals Product Category, End Uses and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Comecer Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Jaco
6.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.7.2 Nuclear Medicine Radiopharmaceuticals Product Category, End Uses and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Jaco Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Ciaeriar
6.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.8.2 Nuclear Medicine Radiopharmaceuticals Product Category, End Uses and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Ciaeriar Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Advanced Molecular-imaging Solution
6.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.9.2 Nuclear Medicine Radiopharmaceuticals Product Category, End Uses and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Advanced Molecular-imaging Solution Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
6.9.4 Main Business/Business Overview
7 Nuclear Medicine Radiopharmaceuticals Manufacturing Cost Analysis
7.1 Nuclear Medicine Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Nuclear Medicine Radiopharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Medicine Radiopharmaceuticals Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Nuclear Medicine Radiopharmaceuticals Market Forecast (2017-2022)
11.1 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.1.1 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
11.1.2 Global Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
11.1.3 Global Nuclear Medicine Radiopharmaceuticals Price and Trend Forecast (2017-2022)
11.2 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Revenue (Million USD) Forecast by Regions (2017-2022)
11.2.1 North America Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
11.2.2 Europe Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
11.2.3 Asia-Pacific Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
11.2.4 South America Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
11.2.5 Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
11.3 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) Forecast by Type (2017-2022)
11.4 Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Table

List of Tables and Figures

Figure Product Picture of Nuclear Medicine Radiopharmaceuticals
Table Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) by Types in 2016
Figure Product Picture of Diagnostic
Table Major Manufacturers of Diagnostic
Figure Product Picture of Brachytherapy
Table Major Manufacturers of Brachytherapy
Figure Product Picture of Other Therapeutic
Table Major Manufacturers of Other Therapeutic
Table Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) Comparison by Applications (2012-2022)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) by Applications in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Thyroid Examples
Table Key Downstream Customer in Cardiology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Nuclear Medicine Radiopharmaceuticals Market Size Comparison and Growth (%) by Regions (2012-2022)
Table Global Market Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) Comparison by Regions 2012-2022
Figure North America Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Asia-Pacific Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Europe Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure South America Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Middle East and Africa Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Global Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) Status and Outlook (2012-2022)
Table Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) of Key Manufacturers (2012-2017)
Table Global Nuclear Medicine Radiopharmaceuticals Sales Share (%) by Manufacturers (2012-2017)
Figure 2016 Nuclear Medicine Radiopharmaceuticals Sales Share (%) by Manufacturers
Figure 2017Nuclear Medicine Radiopharmaceuticals Sales Share (%) by Manufacturers
Table Global Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Nuclear Medicine Radiopharmaceuticals Revenue Share (%) by Manufacturers (2012-2017)
Table 2016 Global Nuclear Medicine Radiopharmaceuticals Revenue Share (%) by Manufacturers
Table 2016 Global Nuclear Medicine Radiopharmaceuticals Revenue Share (%) by Manufacturers
Table Global Market Nuclear Medicine Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Nuclear Medicine Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Nuclear Medicine Radiopharmaceuticals Manufacturing Base Distribution and Sales Area
Table Manufacturers Nuclear Medicine Radiopharmaceuticals Product Category
Figure Nuclear Medicine Radiopharmaceuticals Market Share (%) of Top 3 Manufacturers
Figure Nuclear Medicine Radiopharmaceuticals Market Share (%) of Top 5 Manufacturers
Table Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) by Regions (2012-2017)
Table Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) by Regions (2012-2017)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) by Regions (2012-2017)
Figure 2016 Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) by Regions
Table Global Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) by Regions (2012-2017)
Table Global Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) by Regions (2012-2017)
Figure Global Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) by Regions
Table Global Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table North America Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Europe Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Asia-Pacific Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table South America Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Table Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) by Types (2012-2017)
Table Global Nuclear Medicine Radiopharmaceuticals Sales Share (%) by Types (2012-2017)
Figure Sales Market Share (%) of Nuclear Medicine Radiopharmaceuticals by Types (2012-2017)
Figure 2016 Sales Market Share (%) of Nuclear Medicine Radiopharmaceuticals by Types
Table Global Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) by Types (2012-2017)
Table Global Nuclear Medicine Radiopharmaceuticals Revenue Share (%) by Types (2012-2017)
Figure Revenue Share (%) of Nuclear Medicine Radiopharmaceuticals by Types (2012-2017)
Figure 2016 Revenue Market Share (%) of Nuclear Medicine Radiopharmaceuticals by Types
Table Global Nuclear Medicine Radiopharmaceuticals Price (USD/Unit) by Types (2012-2017)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales Growth (%) by Type (2012-2017)
Table Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) by Applications (2012-2017)
Table Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) by Applications (2012-2017)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) by Applications (2012-2017)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) by Applications in 2016
Table Global Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) by Applications (2012-2017)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) by Applications (2012-2017)
Table Mallinckrodt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mallinckrodt Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Mallinckrodt Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) (2012-2017)
Figure Mallinckrodt Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) (2012-2017)
Figure Mallinckrodt Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) (2012-2017)
Table Isorad Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Isorad Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Isorad Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) (2012-2017)
Figure Isorad Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) (2012-2017)
Figure Isorad Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) (2012-2017)
Table Cardinal Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cardinal Health Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Cardinal Health Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) (2012-2017)
Figure Cardinal Health Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) (2012-2017)
Figure Cardinal Health Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) (2012-2017)
Table Jubilant Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jubilant Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Jubilant Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) (2012-2017)
Figure Jubilant Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) (2012-2017)
Figure Jubilant Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) (2012-2017)
Table Medi-Radiopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Medi-Radiopharma Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Medi-Radiopharma Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) (2012-2017)
Figure Medi-Radiopharma Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) (2012-2017)
Figure Medi-Radiopharma Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) (2012-2017)
Table Comecer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Comecer Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Comecer Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) (2012-2017)
Figure Comecer Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) (2012-2017)
Figure Comecer Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) (2012-2017)
Table Jaco Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jaco Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Jaco Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) (2012-2017)
Figure Jaco Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) (2012-2017)
Figure Jaco Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) (2012-2017)
Table Ciaeriar Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ciaeriar Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Ciaeriar Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) (2012-2017)
Figure Ciaeriar Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) (2012-2017)
Figure Ciaeriar Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) (2012-2017)
Table Advanced Molecular-imaging Solution Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Advanced Molecular-imaging Solution Nuclear Medicine Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Advanced Molecular-imaging Solution Nuclear Medicine Radiopharmaceuticals Sales Growth Rate (%) (2012-2017)
Figure Advanced Molecular-imaging Solution Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) (2012-2017)
Figure Advanced Molecular-imaging Solution Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) (2012-2017)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine Radiopharmaceuticals
Figure Nuclear Medicine Radiopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine Radiopharmaceuticals Major Manufacturers in 2016
Table Major Buyers of Nuclear Medicine Radiopharmaceuticals
Table Distributors/Traders List
Figure Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Global Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Figure Global Nuclear Medicine Radiopharmaceuticals Price and Trend Forecast (2017-2022)
Table Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) Forecast by Regions (2017-2022)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) Forecast by Regions (2017-2022)
Figure North America Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure North America Nuclear Medicine Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Nuclear Medicine Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Nuclear Medicine Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2017-2022)
Figure South America Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure South America Nuclear Medicine Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Nuclear Medicine Radiopharmaceuticals Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Nuclear Medicine Radiopharmaceuticals Revenue and Growth Rate (%) Forecast (2017-2022)
Table Global Nuclear Medicine Radiopharmaceuticals Sales (Million USD) Forecast by Type (2017-2022)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales Market Share (%) Forecast by Type (2017-2022)
Table Global Nuclear Medicine Radiopharmaceuticals Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Nuclear Medicine Radiopharmaceuticals Revenue Market Share (%) Forecast by Type (2017-2022)
Table Global Nuclear Medicine Radiopharmaceuticals Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Nuclear Medicine Radiopharmaceuticals Sales (K Units) Forecast by Application (2017-2022)
Figure Global Nuclear Medicine Radiopharmaceuticals Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *